Clinical significance of cardiac myosin light chain 1 (cMLC1) was investigated in hemodialysis (HD) patients. We performed an echocardiogram and investigated all echocardiographic measurements and analyzed the left ventricular mass index (LVMI) in 127 patients (67 HD patients, 60 non HD patients). Simultaneously, brachial ankle Pulse Wave Velocity (ba PWV) and Ankle Brachial Pressure Index (ABI) was measured using a noninvasive automatic device PWV/ABI (Nihon Colin Co., AT company, Tokyo, Japan), and common carotid artery (CCA) ultrasonography was performed to measure the intima-media thickness (IMT) in the same subjects. Cardiothoracic ratio (CTR) and aortic calcification index (ACI) were also estimated on simple chest X-ray film. The correlations of cMLC1 with the above parameters, laboratory findings including renal function, plasma heart fatty acid-binding protein (H-FABP), cardiac troponin T (cTnT) concentration, and cardiovascular complications were analyzed. For the detection of ischemic heart disease (IHD), multiple regression analysis and receiver operating characteristics (ROC) analysis were performed to estimate the diagnostic efficacy of cMLC1 in HD patients.
The value of cMLC1 was significantly greater in the HD group than in the non HD group (p<0.0001), and was positively correlated with H-FABP/Cr and cTnT in the HD group (r=0.316, p<0.01; r=0.244, p<0.05, respectively). In the HD group, cMLC1 level was significantly greater in the IHD group than in the non IHD group (p<0.05). In the HD group, cMLC1 was negatively correlated with ejection fraction (EF) and percent fractional shortening (%FS) (r=-0.300, p<0.05; r=-0.273, p<0.05, respectively), and was also significantly greater in left ventricular (LV) systolic dysfunction group (EF<50%) than in the normal group (EF≥50%) (p<0.001).
In the HD group, cMLC1 was positively correlated with LVMI, CTR, left ventricular end-systolic dimension (LVDs), left ventricular end-diastolic dimension (LVDd), left ventricular end-systolic volume (LVESV), and left ventricular end-diastolic volume (LVEDV). Multiple regression analysis of IHD demonstrated that cMLC1 was a significantly influential factor. In the HD group, cMLC1 was positively correlated with ba PWV and ACI (r=0.361, p<0.01; r=0.465, p<0.0001, respectively). Multiple regression analysis of ba PWV demonstrated that cMLC1 and systolic blood pressure were significant factors. In the HD group, for the detection of IHD, the area under the ROC curve was 0.692 (p<0.0001) for cMLC1, and sensitivity was 65.0, specificity was 70.4, and the cut-off value was 9.7 (ng/mL). The results of multiple regression and ROC analyses suggest that cMLC1 has a great diagnostic power for the detection of IHD in HD patients.
In conclusion, when the cut-off value was corrected, the value of cMLC1 is a useful and sensitive marker for the detection of IHD and for the evaluation of LV dysfunction and LV hypertrophy even in HD patients.
View full abstract